NCT00596167View on ClinicalTrials.gov

Intradialytic Drug Removal by Short-daily Hemodialysis

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

April 30, 2009

Study Completion Date

September 30, 2009

Conditions
End Stage Renal DiseaseInfection
Interventions
DRUG

Intravenous antibiotics

Each subject will receive a single dose of 15 mg/kg vancomycin; 2 mg/kg gentamicin and 250 mg levofloxacin administered intravenously over a one-hour infusion period through the venous limb of their HD access (or tunneled catheter) via an IV pump.

Trial Locations (1)

46202

Indiana University School of Medicine, Indianapolis

All Listed Sponsors
lead

Indiana University School of Medicine

OTHER

NCT00596167 - Intradialytic Drug Removal by Short-daily Hemodialysis | Biotech Hunter | Biotech Hunter